The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Brief Title: Safety and Efficacy of AIV001 on Low Risk Basal Cell Carcinoma
Official Title: An Exploratory Study to Evaluate the Safety and Efficacy of AIV001 Intradermally Administered in Subjects With Biopsy-confirmed Basal Cell Carcinoma
Study ID: NCT04470726
Brief Summary: To evaluate safety and efficacy of AIV001 treatment on low-risk basal cell carcinoma.
Detailed Description:
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
California Dermatology & Clinical Research Institute, Encinitas, California, United States
Island Dermatology, Newport Beach, California, United States
Austin Institute for Clinical Research, Pflugerville, Texas, United States